Neumora Launches With $500m To Advance Personalized Neuroscience Drugs

Funding Includes $100m Under New Amgen Deal

 
• By Mandy Jackson
  
Venture capital; Businessman pressing virtual screen inscription
Neumora raised more than $400m to build the company at scale and develop multiple programs at once • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business